Eli Lilly

Express Scripts targets Amgen, Lilly migraine drugs in pricing shift
Express Scripts targets Amgen, Lilly migraine drugs in pricing shift
Reuters
Express Scripts
migraines
PBMs
Amgen
Eli Lilly
Flag link:
Lilly’s strong Q1 cushions the blow of FDA thumbs-down on high-dose baricitinib
Lilly’s strong Q1 cushions the blow of FDA thumbs-down on high-dose baricitinib
Fierce Pharma
Eli Lilly
earnings
baricitinib
Flag link:
FDA Panel Splits on Lilly Arthritis Drug, Backs Lower of Two Doses
FDA Panel Splits on Lilly Arthritis Drug, Backs Lower of Two Doses
Xconomy
Eli Lilly
FDA
advisory panels
rheumatoid arthritis
baricitinib
Incyte
Flag link:
Big Week Ahead for Eli Lilly: Here's What to Look For
Big Week Ahead for Eli Lilly: Here's What to Look For
Motley Fool
Eli Lilly
earnings
FDA
Incyte
olumiant
rheumatoid arthritis
Flag link:
Safety Concerns Linger for Lilly’s Arthritis Drug as FDA Panel Looms
Safety Concerns Linger for Lilly’s Arthritis Drug as FDA Panel Looms
Xconomy
Eli Lilly
baricitinib
olumiant
rheumatoid arthritis
Flag link:
Pfizer's Deal Potential Doesn't Stop at Bristol-Myers
Pfizer's Deal Potential Doesn't Stop at Bristol-Myers
Bloomberg
Pfizer
M&A
Bristol-Myers Squibb
Celgene
Eli Lilly
AstraZeneca
Flag link:
Payer Power: Why Eli Lilly, Janssen, and Merck Deeply Discount Their Drug Prices
Payer Power: Why Eli Lilly, Janssen, and Merck Deeply Discount Their Drug Prices
Drug Channels
Eli Lilly
Janssen
Merck
drug pricing
drug discounts
Flag link:
Pharma turns to new pain options amid opioid crisis
Pharma turns to new pain options amid opioid crisis
Biopharma Dive
opioids
opioid crisis
painkillers
payers
Eli Lilly
abuse deterrents
Flag link:
Eli Lilly inks $63m deal with Sigilon to develop encapsulated cell therapies for diabetes
Eli Lilly inks $63m deal with Sigilon to develop encapsulated cell therapies for diabetes
Drug Delivery Business News
Eli Lilly
Sigilon
cell therapies
drug development
type 1 diabetes
Flag link:
Lilly's Cyramza succeeds in late-stage liver cancer trial
Lilly's Cyramza succeeds in late-stage liver cancer trial
Yahoo/Reuters
Eli Lilly
Cyramza
liver cancer
clinical trials
Flag link:
Tired of finishing in last place, Eli Lilly’s new R&D chief wants to shake things up
Tired of finishing in last place, Eli Lilly’s new R&D chief wants to shake things up
Endpoints
Eli Lilly
R&D
Dan Skovronsky
Flag link:
Half-off sale at Eli Lilly as drug rebating climbs to 51% in 2017
Half-off sale at Eli Lilly as drug rebating climbs to 51% in 2017
Fierce Pharma
Eli Lilly
drug rebates
drug pricing
diabetes
Flag link:
Investors in AbbVie, Lilly, Amgen and more set to vote on executive pay, drug pricing
Investors in AbbVie, Lilly, Amgen and more set to vote on executive pay, drug pricing
Fierce Pharma
AbbVie
Eli Lilly
Amgen
executive pay
drug pricing
Flag link:
Lilly's bet on pain stands out amid bare pharma pipeline
Lilly's bet on pain stands out amid bare pharma pipeline
Biopharma Dive
Eli Lilly
painkillers
galcanezumab
tanezumab
Lasmiditan
Flag link:
CVS to Hire Former Eli Lilly CFO to Run Pharmacy Benefit Business
CVS to Hire Former Eli Lilly CFO to Run Pharmacy Benefit Business
Morningstar
CVS
Eli Lilly
PBMs
Flag link:
In wake of Eli Lilly setback, Merck KGaA’s leading BTK drug for autoimmune disease clears PhIIb hurdle
In wake of Eli Lilly setback, Merck KGaA’s leading BTK drug for autoimmune disease clears PhIIb hurdle
Endpoints
Eli Lilly
Merck KGaA
Btk inhibitors
autoimmune disease
evobrutinib
Flag link:
Lilly, Boehringer add two Jardiance heart failure studies to examine effects on exercise
Lilly, Boehringer add two Jardiance heart failure studies to examine effects on exercise
Fierce Pharma
Eli Lilly
Boehringer Ingelheim
Jardiance
heart failure
exercise
diabetes
Flag link:
Migraine maven Lilly finds 'understanding gap' between patients, nonpatients in new survey
Migraine maven Lilly finds 'understanding gap' between patients, nonpatients in new survey
Fierce Pharma
migraines
Eli Lilly
patients
Flag link:
Large and Small: Here’s What’s Moving Eli Lilly and Zosano
Large and Small: Here’s What’s Moving Eli Lilly and Zosano
Yahoo/Market Exclusive
Eli Lilly
Zosano
Verzenio
advanced breast cancer
M207
migraine
Flag link:
Lilly touts Ph3 data for once-weekly Type II diabetes medication
Lilly touts Ph3 data for once-weekly Type II diabetes medication
Drug Delivery Business News
Eli Lilly
diabetes
clinical trials
Trulicity
Flag link:

Pages